Document Detail

Antimicrobial agents and host defence.
MedLine Citation:
PMID:  6598518     Owner:  NLM     Status:  MEDLINE    
Reports from different laboratories on effects of different antibiotics on host defence are often hard to compare because of differences in experimental design. The purpose of this presentation was to describe the effect of many different antibiotics with the same standardized techniques. E. coli and S. aureus pre-exposed to different beta-lactam antibiotics or gentamicin in subinhibitory concentrations were more susceptible to phagocytosis and killing by granulocytes than non-treated bacteria. A markedly depressed chemotaxis was detected when human leucocytes were incubated with fusidic acid and rifampicin in clinically obtainable concentration and well absorbed tetracyclines at high concentrations. The incorporation of 14C-leucine into a trichloracetic-acid insoluble form by human neutrophils was markedly depressed by the same antibiotics. Many other antibiotics did not inhibit granulocyte or lymphocyte functions. At therapeutic concentrations fusidic acid and rifampicin had a pronounced inhibition effect on the incorporation of 3H-thymidine by human T-lymphocytes stimulated by PHA and B-lymphocytes by S. aureus, Cowan I. At concentrations above the therapeutic level, inhibition was detected for doxycycline, erythromycin, clindamycin and nitrofurantoin. Due to high albumin binding for some of the tested antibiotics and other factors involved, experiments were performed to test whether depression also takes place in vivo. The cellular immunity in mice was registered by monitoring the survival of transplanted heart grafts. Rifampicin at human therapeutic dose had a strong inhibiting effect (p less than 0.001) on the rejection of heart grafts. The effect of doxycycline (2.5 mg/kg/day) and fusidic acid (25 mg/kg/day) was slight but significant (p less than 0.02).
A Forsgren
Related Documents :
22975258 - Degradation of 2,4-dihydroxibenzoic acid by vacuum uv process in aqueous solution: kine...
8626248 - Himastatin, a new antitumor antibiotic from streptomyces hygroscopicus. iii. structural...
16232908 - Production and structural analysis of pp-v, a homologue of monascorubramine, produced b...
24294998 - Comparative study of the use of sarcosine, proline, and glycine as acrylamide inhibitor...
16292868 - Facile preparation of a new binap-based building block, 5,5'-diiodobinap, and its synth...
6107268 - Acute effects of insulin on fatty acid metabolism in isolated rat hepatocytes.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Scandinavian journal of infectious diseases. Supplementum     Volume:  43     ISSN:  0300-8878     ISO Abbreviation:  Scand J Infect Dis Suppl     Publication Date:  1984  
Date Detail:
Created Date:  1985-06-25     Completed Date:  1985-06-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0251025     Medline TA:  Scand J Infect Dis Suppl     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  24-33     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / blood,  pharmacology*
Chemotaxis, Leukocyte / drug effects
Graft Rejection / drug effects
Immunity / drug effects*
Lymphocyte Activation / drug effects
Lymphocytes / immunology,  metabolism
Mice, Inbred CBA
Mice, Inbred DBA
Neutrophils / metabolism
Phagocytosis / drug effects
Transplantation Immunology / drug effects
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prostaglandin D2 in subarachnoid hemorrhage. Biological and diagnostic implications
Next Document:  Clindamycin resistance in anaerobic bacteria.